Similarly, BRCA1-, but not BRCA2-, breast cancers was also associated with higher PD-1 (PDCD1) expression compared to BRCA-proficient breast cancers in both WSI and TCGA cohorts (PBRCA1: 0.013 and 7.2 x 10−3, respectively. This evidence concerns the gene BRCA2 and breast carcinoma.